Literature DB >> 7796554

Vibroacoustic stimulation.

C V Smith1.   

Abstract

Vibroacoustic stimulation of the human fetus profoundly alters fetal behavior and heart rate. Many authors have reported success using this technique to improve the efficiency of antepartum fetal heart rate testing without changing the predictive reliability of the tests. Vibroacoustic stimulation has other potential advantages in the antepartum assessment of fetal well-being and in provoking fetal activity to improve ultrasonic visualization. From an experimental standpoint, vibroacoustic stimulation offers a unique opportunity to assess how the fetus responds to the external environment. The available information suggests that exposure of the fetus to vibroacoustic stimulation is clinically safe. Additional research is needed to characterize the optimal frequency, duration, intensity, and choice of stimulus to provide consistent responses. The literature presents a confusing array of studies using different methods, which makes comparison of results among institutions and investigators difficult. Vibroacoustic stimulation appears to be a reasonable and safe clinical technique. Additional prospective investigation is necessary to characterize further how this technique can be more useful clinically.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796554     DOI: 10.1097/00003081-199503000-00009

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  2 in total

1.  A melodic contour repeatedly experienced by human near-term fetuses elicits a profound cardiac reaction one month after birth.

Authors:  Carolyn Granier-Deferre; Sophie Bassereau; Aurélie Ribeiro; Anne-Yvonne Jacquet; Anthony J Decasper
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

2.  Applicability of the rapid biophysical profile in antepartum fetal well-being assessment in high-risk pregnancies from a university hospital in são paulo, Brazil: preliminary results.

Authors:  Jonathan Mamber Czeresnia; Edward Araujo Júnior; Eduardo Cordioli; Wellington P Martins; Luciano Marcondes Machado Nardozza; Antonio Fernandes Moron
Journal:  ISRN Obstet Gynecol       Date:  2013-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.